The store will not work correctly when cookies are disabled.
(1R,2S)-1-hydroxypropane-1,2,3-tricarboxylic acid
ID: ALA390356
Chembl Id: CHEMBL390356
Cas Number: 18979-21-0
PubChem CID: 5318532
Max Phase: Preclinical
Molecular Formula: C6H8O7
Molecular Weight: 192.12
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Synonyms: Isocitric acid | D-threo-Isocitric acid|6061-97-8|(1R,2S)-1-hydroxypropane-1,2,3-tricarboxylic acid|CHEBI:151|(+)-threo-isocitric acid|3-carboxy-2,3-dideoxy-L-threo-pentaric acid|(1R,2S)-1-Hydroxypropane-1,2,3-tricarboxylate|ICT|rel-(1S,2R)-1-Hydroxypropane-1,2,3-tricarboxylic acid|18979-21-0|Threo-isocitrate|1grp|DS-threo-isocitrate|(+)-threo-isocitrate|(2R,3S)-Isocitrate|DS-threo-isocitric acid|Threo-DS(+)-isocitrate|Threo-d-(+)-isocitrate|bmse000025|Threo-DS(+)-isocitric acid|Threo-d-(+)-isocShow More⌵
Canonical SMILES: O=C(O)C[C@H](C(=O)O)[C@@H](O)C(=O)O
Standard InChI: InChI=1S/C6H8O7/c7-3(8)1-2(5(10)11)4(9)6(12)13/h2,4,9H,1H2,(H,7,8)(H,10,11)(H,12,13)/t2-,4+/m0/s1
Standard InChI Key: ODBLHEXUDAPZAU-ZAFYKAAXSA-N
Associated Targets(non-human)
Molecule Features
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 192.12 | Molecular Weight (Monoisotopic): 192.0270 | AlogP: -1.39 | #Rotatable Bonds: 5 |
Polar Surface Area: 132.13 | Molecular Species: ACID | HBA: 4 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.07 | CX Basic pKa: | CX LogP: -1.45 | CX LogD: -9.58 |
Aromatic Rings: 0 | Heavy Atoms: 13 | QED Weighted: 0.42 | Np Likeness Score: 1.22 |
References
1. Yamamoto T, Miyazaki K, Eguchi T.. (2007) Substrate specificity analysis and inhibitor design of homoisocitrate dehydrogenase., 15 (3): [PMID:17116397] [10.1016/j.bmc.2006.11.008] |
2. Langley GW, Abboud MI, Lohans CT, Schofield CJ.. (2019) Inhibition of a viral prolyl hydroxylase., 27 (12): [PMID:30737136] [10.1016/j.bmc.2019.01.018] |